RHON-KLINIKUM AG Unsponsored ADR
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a RKAGY research report →
Companywww.rhoen-klinikum-ag.com
RHÖN-KLINIKUM Aktiengesellschaft, together with its subsidiaries, offers in-patient, semi-patient, and outpatient healthcare services in Germany. Its hospitals offer treatment services, including rehabilitation of cardiovascular patients, hand surgery, neurological, psychosomatic, addiction therapy facilities, ophthalmology, trauma surgery, dentistry, thoracic, pulmonary, vascular, tumors, neurological conditions, and treatment of spinal column, joints, and heart diseases. It operates eight hospitals and 5,420 beds/places at five medical sites.
- CEO
- Stefan Stranz
- IPO
- 2013
- Employees
- 18,819
- HQ
- Bad Neustadt an der Saale, DE
Price Chart
Valuation
- Market Cap
- $1.09B
- P/E
- 21.06
- P/S
- 0.49
- P/B
- 0.63
- EV/EBITDA
- 6.78
- Div Yield
- 0.79%
Profitability
- Gross Margin
- -1.25%
- Op Margin
- 2.83%
- Net Margin
- 2.32%
- ROE
- 3.04%
- ROIC
- 2.66%
Growth & Income
- Revenue
- $1.86B · 16.53%
- Net Income
- $33.11M · -23.62%
- EPS
- $0.25 · -26.87%
- Op Income
- $4.22M
- FCF YoY
- -158.10%
Performance & Tape
- 52W High
- $8.16
- 52W Low
- $7.31
- 50D MA
- $8.16
- 200D MA
- $7.70
- Beta
- -0.00
- Avg Volume
- 41.072
Get TickerSpark's AI analysis on RKAGY
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Our RKAGY Coverage
We haven't published any research on RKAGY yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate RKAGY Report →